Susanne E. Churchill, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Electronic Health Records | 24 | 2019 | 4279 | 0.720 |
Why?
|
| Inflammatory Bowel Diseases | 12 | 2019 | 2286 | 0.550 |
Why?
|
| Colitis, Ulcerative | 8 | 2019 | 1824 | 0.470 |
Why?
|
| Crohn Disease | 8 | 2019 | 2256 | 0.440 |
Why?
|
| Natural Language Processing | 10 | 2019 | 953 | 0.420 |
Why?
|
| Algorithms | 16 | 2021 | 13758 | 0.350 |
Why?
|
| Information Storage and Retrieval | 6 | 2019 | 835 | 0.320 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2012 | 604 | 0.310 |
Why?
|
| Arthritis, Rheumatoid | 9 | 2015 | 3645 | 0.260 |
Why?
|
| Antidepressive Agents | 5 | 2016 | 2827 | 0.220 |
Why?
|
| Medical Record Linkage | 1 | 2021 | 286 | 0.190 |
Why?
|
| Vitamin D | 4 | 2015 | 3193 | 0.190 |
Why?
|
| Depressive Disorder, Major | 5 | 2014 | 4454 | 0.170 |
Why?
|
| Phenotype | 9 | 2019 | 16311 | 0.160 |
Why?
|
| Depressive Disorder | 4 | 2016 | 3804 | 0.160 |
Why?
|
| Clostridium Infections | 2 | 2014 | 507 | 0.150 |
Why?
|
| Tumor Necrosis Factor-alpha | 3 | 2016 | 4454 | 0.140 |
Why?
|
| Hospitalization | 5 | 2014 | 9745 | 0.130 |
Why?
|
| Autoantibodies | 3 | 2013 | 2008 | 0.130 |
Why?
|
| Cohort Studies | 18 | 2016 | 40032 | 0.130 |
Why?
|
| Gastrointestinal Agents | 2 | 2016 | 494 | 0.120 |
Why?
|
| High-Throughput Screening Assays | 1 | 2019 | 933 | 0.120 |
Why?
|
| Vitamin D Deficiency | 2 | 2013 | 1373 | 0.120 |
Why?
|
| Blood Sedimentation | 1 | 2014 | 234 | 0.120 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2016 | 2328 | 0.110 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2014 | 438 | 0.110 |
Why?
|
| Cholangitis, Sclerosing | 1 | 2014 | 155 | 0.110 |
Why?
|
| Confidentiality | 2 | 2019 | 603 | 0.110 |
Why?
|
| Sex Ratio | 1 | 2012 | 103 | 0.110 |
Why?
|
| Data Mining | 1 | 2017 | 552 | 0.110 |
Why?
|
| Antibodies, Antinuclear | 1 | 2013 | 340 | 0.110 |
Why?
|
| Systems Integration | 2 | 2011 | 446 | 0.110 |
Why?
|
| Biomedical Research | 3 | 2013 | 3268 | 0.100 |
Why?
|
| Anxiety Disorders | 2 | 2013 | 2578 | 0.100 |
Why?
|
| Software | 4 | 2014 | 4396 | 0.100 |
Why?
|
| Antidepressive Agents, Second-Generation | 1 | 2014 | 511 | 0.100 |
Why?
|
| Sjogren's Syndrome | 1 | 2013 | 239 | 0.100 |
Why?
|
| Colorectal Neoplasms | 3 | 2016 | 6592 | 0.100 |
Why?
|
| Parturition | 1 | 2014 | 400 | 0.100 |
Why?
|
| New England | 4 | 2014 | 1008 | 0.100 |
Why?
|
| Adult | 31 | 2016 | 212279 | 0.090 |
Why?
|
| Hospital Shared Services | 1 | 2009 | 15 | 0.090 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 2 | 2016 | 3601 | 0.090 |
Why?
|
| Medical Informatics Applications | 1 | 2011 | 182 | 0.090 |
Why?
|
| Lipoproteins, LDL | 1 | 2013 | 654 | 0.090 |
Why?
|
| Boston | 5 | 2016 | 9377 | 0.090 |
Why?
|
| Logistic Models | 9 | 2015 | 13623 | 0.090 |
Why?
|
| Data Interpretation, Statistical | 2 | 2019 | 2729 | 0.090 |
Why?
|
| Limbic System | 1 | 2012 | 436 | 0.090 |
Why?
|
| Male | 38 | 2016 | 350352 | 0.090 |
Why?
|
| Immunologic Factors | 2 | 2015 | 1571 | 0.090 |
Why?
|
| Lipoproteins | 1 | 2013 | 914 | 0.080 |
Why?
|
| Database Management Systems | 1 | 2010 | 288 | 0.080 |
Why?
|
| Female | 40 | 2016 | 377229 | 0.080 |
Why?
|
| Humans | 53 | 2021 | 715818 | 0.080 |
Why?
|
| Hypothyroidism | 1 | 2013 | 649 | 0.080 |
Why?
|
| Thromboembolism | 1 | 2014 | 985 | 0.080 |
Why?
|
| Diabetes Mellitus | 2 | 2015 | 5463 | 0.080 |
Why?
|
| Autistic Disorder | 1 | 2016 | 1068 | 0.080 |
Why?
|
| Carbon Monoxide Poisoning | 1 | 2007 | 66 | 0.080 |
Why?
|
| Hospital Information Systems | 1 | 2009 | 364 | 0.080 |
Why?
|
| Delivery, Obstetric | 1 | 2014 | 907 | 0.080 |
Why?
|
| Middle Aged | 28 | 2016 | 214666 | 0.080 |
Why?
|
| Risk Factors | 16 | 2016 | 70879 | 0.080 |
Why?
|
| Hyperbaric Oxygenation | 1 | 2007 | 160 | 0.080 |
Why?
|
| Accidental Falls | 1 | 2014 | 1037 | 0.070 |
Why?
|
| Colonoscopy | 1 | 2014 | 1315 | 0.070 |
Why?
|
| Medical Informatics | 1 | 2013 | 737 | 0.070 |
Why?
|
| Cesarean Section | 1 | 2014 | 1321 | 0.070 |
Why?
|
| Dyslipidemias | 1 | 2013 | 847 | 0.070 |
Why?
|
| User-Computer Interface | 2 | 2010 | 1439 | 0.070 |
Why?
|
| Hydroxybutyrate Dehydrogenase | 2 | 1996 | 8 | 0.070 |
Why?
|
| Genome-Wide Association Study | 4 | 2014 | 11940 | 0.070 |
Why?
|
| DNA Copy Number Variations | 1 | 2014 | 1894 | 0.070 |
Why?
|
| Genetic Association Studies | 1 | 2014 | 2720 | 0.060 |
Why?
|
| Pregnancy, Animal | 2 | 1982 | 131 | 0.060 |
Why?
|
| Weight Gain | 1 | 2014 | 2221 | 0.060 |
Why?
|
| International Classification of Diseases | 3 | 2018 | 855 | 0.060 |
Why?
|
| Models, Genetic | 1 | 2014 | 3516 | 0.060 |
Why?
|
| Decision Support Techniques | 1 | 2014 | 2032 | 0.060 |
Why?
|
| Apolipoprotein E4 | 1 | 2007 | 612 | 0.060 |
Why?
|
| Genotype | 6 | 2015 | 12919 | 0.060 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2010 | 1207 | 0.060 |
Why?
|
| Multivariate Analysis | 5 | 2015 | 12483 | 0.060 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2013 | 17409 | 0.060 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2013 | 2144 | 0.060 |
Why?
|
| Case-Control Studies | 7 | 2014 | 21795 | 0.060 |
Why?
|
| Kidney | 3 | 1991 | 6882 | 0.060 |
Why?
|
| Risk Assessment | 5 | 2016 | 23476 | 0.060 |
Why?
|
| Lipids | 1 | 2013 | 3242 | 0.060 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2012 | 2279 | 0.050 |
Why?
|
| Wounds and Injuries | 1 | 2014 | 2415 | 0.050 |
Why?
|
| C-Reactive Protein | 1 | 2014 | 3713 | 0.050 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2012 | 2193 | 0.050 |
Why?
|
| Health Services Research | 1 | 2009 | 1840 | 0.050 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2016 | 3149 | 0.050 |
Why?
|
| Comorbidity | 2 | 2013 | 10435 | 0.050 |
Why?
|
| Follow-Up Studies | 7 | 2016 | 39305 | 0.050 |
Why?
|
| Bipolar Disorder | 2 | 2014 | 5054 | 0.050 |
Why?
|
| Artificial Intelligence | 1 | 2011 | 1744 | 0.050 |
Why?
|
| Prognosis | 6 | 2016 | 29007 | 0.050 |
Why?
|
| Diuresis | 2 | 1991 | 115 | 0.050 |
Why?
|
| Electrocardiography | 1 | 2013 | 6386 | 0.050 |
Why?
|
| Multiple Sclerosis | 1 | 2013 | 3002 | 0.040 |
Why?
|
| Psychiatry | 1 | 2011 | 1623 | 0.040 |
Why?
|
| Aged | 14 | 2016 | 162468 | 0.040 |
Why?
|
| Prevalence | 2 | 2014 | 14912 | 0.040 |
Why?
|
| Anticoagulants | 1 | 2014 | 4375 | 0.040 |
Why?
|
| Incidence | 5 | 2014 | 20733 | 0.040 |
Why?
|
| Severity of Illness Index | 2 | 2013 | 15911 | 0.040 |
Why?
|
| Urine | 3 | 1991 | 381 | 0.040 |
Why?
|
| Genomics | 2 | 2011 | 5342 | 0.040 |
Why?
|
| Models, Biological | 2 | 2013 | 9809 | 0.040 |
Why?
|
| Risk | 3 | 2015 | 9799 | 0.040 |
Why?
|
| Child, Preschool | 3 | 2016 | 41198 | 0.040 |
Why?
|
| Registries | 1 | 2012 | 8048 | 0.040 |
Why?
|
| Young Adult | 7 | 2016 | 56228 | 0.040 |
Why?
|
| Coronary Artery Disease | 1 | 2015 | 6290 | 0.040 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2021 | 790 | 0.030 |
Why?
|
| Unified Medical Language System | 1 | 2015 | 88 | 0.030 |
Why?
|
| Neoplasms | 2 | 2014 | 20528 | 0.030 |
Why?
|
| Adolescent | 5 | 2016 | 85157 | 0.030 |
Why?
|
| Blood Volume | 2 | 1991 | 587 | 0.030 |
Why?
|
| ROC Curve | 2 | 2014 | 3525 | 0.030 |
Why?
|
| Mitochondria, Liver | 1 | 1996 | 223 | 0.030 |
Why?
|
| Nortriptyline | 1 | 2014 | 83 | 0.030 |
Why?
|
| Amitriptyline | 1 | 2014 | 112 | 0.030 |
Why?
|
| Phosphatidylcholines | 1 | 1996 | 435 | 0.030 |
Why?
|
| Rectal Fistula | 1 | 2014 | 74 | 0.030 |
Why?
|
| United States | 7 | 2019 | 67910 | 0.030 |
Why?
|
| Genetic Research | 1 | 2014 | 165 | 0.030 |
Why?
|
| Area Under Curve | 1 | 2018 | 1688 | 0.030 |
Why?
|
| Research Design | 1 | 2009 | 5902 | 0.030 |
Why?
|
| England | 1 | 2014 | 517 | 0.030 |
Why?
|
| Saimiri | 2 | 1991 | 336 | 0.030 |
Why?
|
| Cognition Disorders | 1 | 2007 | 3975 | 0.030 |
Why?
|
| Medical Audit | 1 | 2014 | 480 | 0.030 |
Why?
|
| Potassium | 2 | 1991 | 1329 | 0.030 |
Why?
|
| Thyroiditis | 1 | 2013 | 84 | 0.030 |
Why?
|
| Osmolar Concentration | 2 | 1991 | 696 | 0.030 |
Why?
|
| Feasibility Studies | 2 | 2012 | 4905 | 0.030 |
Why?
|
| Bupropion | 1 | 2014 | 297 | 0.030 |
Why?
|
| Fornix, Brain | 1 | 2012 | 69 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2012 | 24796 | 0.030 |
Why?
|
| Transglutaminases | 1 | 2013 | 189 | 0.030 |
Why?
|
| Odds Ratio | 2 | 2015 | 9985 | 0.030 |
Why?
|
| Seroepidemiologic Studies | 1 | 2013 | 375 | 0.030 |
Why?
|
| Pregnancy | 5 | 2016 | 27398 | 0.030 |
Why?
|
| Iodide Peroxidase | 1 | 2013 | 279 | 0.030 |
Why?
|
| Water-Electrolyte Balance | 2 | 1991 | 349 | 0.030 |
Why?
|
| Natriuresis | 1 | 1991 | 124 | 0.030 |
Why?
|
| Cholangiopancreatography, Endoscopic Retrograde | 1 | 2014 | 488 | 0.030 |
Why?
|
| Citalopram | 1 | 2014 | 410 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2019 | 2054 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1996 | 1550 | 0.030 |
Why?
|
| Child | 3 | 2016 | 74468 | 0.030 |
Why?
|
| Health Insurance Portability and Accountability Act | 1 | 2011 | 99 | 0.030 |
Why?
|
| Sample Size | 1 | 2014 | 823 | 0.030 |
Why?
|
| Peptides, Cyclic | 1 | 2013 | 403 | 0.020 |
Why?
|
| Mother-Child Relations | 1 | 2014 | 496 | 0.020 |
Why?
|
| Hyperlipidemias | 1 | 2015 | 803 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2013 | 15102 | 0.020 |
Why?
|
| Kinetics | 3 | 1996 | 6654 | 0.020 |
Why?
|
| Infant | 1 | 2012 | 34569 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2018 | 1743 | 0.020 |
Why?
|
| Computer Systems | 1 | 2011 | 479 | 0.020 |
Why?
|
| Causality | 1 | 2016 | 1180 | 0.020 |
Why?
|
| Digestive System Surgical Procedures | 1 | 2014 | 565 | 0.020 |
Why?
|
| Serum Albumin | 1 | 2012 | 679 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2015 | 982 | 0.020 |
Why?
|
| Anisotropy | 1 | 2012 | 1245 | 0.020 |
Why?
|
| GTP-Binding Proteins | 1 | 2013 | 971 | 0.020 |
Why?
|
| Proportional Hazards Models | 2 | 2014 | 12460 | 0.020 |
Why?
|
| Methotrexate | 1 | 2015 | 1725 | 0.020 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2014 | 759 | 0.020 |
Why?
|
| Electronics | 1 | 2009 | 290 | 0.020 |
Why?
|
| Aldosterone | 2 | 1991 | 819 | 0.020 |
Why?
|
| Cross-Sectional Studies | 3 | 2013 | 23437 | 0.020 |
Why?
|
| Drug Interactions | 1 | 2012 | 1466 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2014 | 3543 | 0.020 |
Why?
|
| Pressure | 1 | 1991 | 1234 | 0.020 |
Why?
|
| Arginine Vasopressin | 1 | 1987 | 133 | 0.020 |
Why?
|
| Disease Progression | 2 | 2014 | 13215 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2014 | 15198 | 0.020 |
Why?
|
| Kidney Medulla | 1 | 1987 | 182 | 0.020 |
Why?
|
| Colectomy | 1 | 2012 | 650 | 0.020 |
Why?
|
| Goals | 1 | 2011 | 650 | 0.020 |
Why?
|
| Time Factors | 3 | 2014 | 40887 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2014 | 19537 | 0.020 |
Why?
|
| Remission Induction | 1 | 2012 | 2394 | 0.020 |
Why?
|
| Creatinine | 1 | 2012 | 1898 | 0.020 |
Why?
|
| Databases, Factual | 1 | 2021 | 7901 | 0.020 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2016 | 1785 | 0.020 |
Why?
|
| Gyrus Cinguli | 1 | 2012 | 1070 | 0.020 |
Why?
|
| Hemoglobins | 1 | 2012 | 1502 | 0.020 |
Why?
|
| Nerve Fibers, Myelinated | 1 | 2012 | 980 | 0.020 |
Why?
|
| Brain | 1 | 2012 | 25208 | 0.020 |
Why?
|
| Vasopressins | 1 | 1987 | 370 | 0.020 |
Why?
|
| Retrospective Studies | 4 | 2014 | 72473 | 0.020 |
Why?
|
| Extremities | 1 | 1991 | 871 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2016 | 6552 | 0.020 |
Why?
|
| Peptides | 1 | 2018 | 4384 | 0.020 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2012 | 34430 | 0.020 |
Why?
|
| Escherichia coli | 2 | 1996 | 4277 | 0.020 |
Why?
|
| Serotonin Uptake Inhibitors | 1 | 2012 | 1426 | 0.020 |
Why?
|
| Alleles | 1 | 2015 | 7099 | 0.020 |
Why?
|
| Gene Frequency | 1 | 2011 | 3722 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2014 | 6730 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 2 | 2013 | 15603 | 0.010 |
Why?
|
| Prospective Studies | 2 | 2019 | 51317 | 0.010 |
Why?
|
| Kidney Tubules, Distal | 1 | 1982 | 46 | 0.010 |
Why?
|
| Forecasting | 1 | 2011 | 2956 | 0.010 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2012 | 6183 | 0.010 |
Why?
|
| Research | 1 | 2010 | 2016 | 0.010 |
Why?
|
| Massachusetts | 1 | 2014 | 8743 | 0.010 |
Why?
|
| Computer Simulation | 1 | 2014 | 6105 | 0.010 |
Why?
|
| Patient Readmission | 1 | 2014 | 2980 | 0.010 |
Why?
|
| Urodynamics | 1 | 1982 | 359 | 0.010 |
Why?
|
| Treatment Outcome | 3 | 2012 | 62040 | 0.010 |
Why?
|
| Genetic Variation | 1 | 2015 | 6664 | 0.010 |
Why?
|
| Ambulatory Care | 1 | 2011 | 2768 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2012 | 8075 | 0.010 |
Why?
|
| Kidney Tubules, Proximal | 1 | 1982 | 429 | 0.010 |
Why?
|
| Sodium | 2 | 1982 | 1599 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2014 | 14902 | 0.010 |
Why?
|
| Survival Rate | 1 | 2014 | 13213 | 0.010 |
Why?
|
| Models, Theoretical | 1 | 2011 | 3579 | 0.010 |
Why?
|
| Cloning, Molecular | 2 | 1996 | 4439 | 0.010 |
Why?
|
| Academic Medical Centers | 1 | 2009 | 2790 | 0.010 |
Why?
|
| Sex Factors | 1 | 2013 | 10666 | 0.010 |
Why?
|
| Enzyme Activation | 2 | 1996 | 3818 | 0.010 |
Why?
|
| Rats | 4 | 1996 | 24852 | 0.010 |
Why?
|
| Aged, 80 and over | 2 | 2014 | 58326 | 0.010 |
Why?
|
| Diagnostic Imaging | 1 | 2011 | 3494 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2014 | 12535 | 0.010 |
Why?
|
| Microsomes, Liver | 1 | 1996 | 183 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2012 | 9004 | 0.010 |
Why?
|
| Longitudinal Studies | 1 | 2011 | 13643 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2007 | 6873 | 0.010 |
Why?
|
| Spectrometry, Fluorescence | 1 | 1996 | 717 | 0.010 |
Why?
|
| 3-Hydroxybutyric Acid | 1 | 1993 | 81 | 0.010 |
Why?
|
| Hydroxybutyrates | 1 | 1993 | 84 | 0.010 |
Why?
|
| Depression | 1 | 2013 | 7268 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1996 | 1890 | 0.010 |
Why?
|
| Liposomes | 1 | 1996 | 744 | 0.010 |
Why?
|
| Animals | 6 | 1996 | 169404 | 0.010 |
Why?
|
| Mutagenesis | 1 | 1996 | 1281 | 0.010 |
Why?
|
| Asthma | 1 | 2009 | 5945 | 0.010 |
Why?
|
| Hemodynamics | 1 | 1980 | 4214 | 0.010 |
Why?
|
| DNA, Complementary | 1 | 1993 | 2086 | 0.010 |
Why?
|
| Phospholipids | 1 | 1993 | 792 | 0.010 |
Why?
|
| NAD | 1 | 1993 | 616 | 0.010 |
Why?
|
| Homeostasis | 1 | 1980 | 3332 | 0.010 |
Why?
|
| Cardiovascular Diseases | 1 | 2013 | 14438 | 0.010 |
Why?
|
| Protein Conformation | 1 | 1996 | 4041 | 0.010 |
Why?
|
| Deamino Arginine Vasopressin | 1 | 1987 | 98 | 0.000 |
Why?
|
| Recombinant Proteins | 1 | 1996 | 6803 | 0.000 |
Why?
|
| Tyrosine | 1 | 1987 | 1506 | 0.000 |
Why?
|
| Gene Expression | 1 | 1993 | 7954 | 0.000 |
Why?
|
| Extracellular Space | 1 | 1980 | 606 | 0.000 |
Why?
|
| Kidney Tubules | 1 | 1980 | 496 | 0.000 |
Why?
|
| Liver | 1 | 1993 | 7594 | 0.000 |
Why?
|
| Regional Blood Flow | 1 | 1980 | 1558 | 0.000 |
Why?
|
| Glomerular Filtration Rate | 1 | 1980 | 2104 | 0.000 |
Why?
|